Effects of improvement in aerobic power on resting insulin and glucose concentrations in children

R G McMurray1, M J Bauman, J S Harrell

  • 1Department of Exercise and Sport Science, University of North Carolina, Chapel Hill, N.C. 27599-8700, USA. exphys@unc.edu

Insights

Improving aerobic power (VO2max) in children can lower high insulin levels, especially when combined with exercise. Leisure-time physical activity alone does not impact insulin unless it boosts VO2max.

Area of Science:

  • Pediatric Endocrinology
  • Exercise Physiology
  • Metabolic Health

Background:

  • Childhood obesity and metabolic health are growing concerns.
  • Understanding factors influencing insulin and glucose levels in children is crucial.
  • Aerobic fitness, body composition, and physical activity are key modulators.

Purpose of the Study:

  • To investigate the impact of enhanced aerobic power (VO2max) on fasting insulin and glucose in children.
  • To analyze these relationships while controlling for body fat, gender, pubertal status, and leisure-time physical activity (LTPA).
  • To determine if an aerobic exercise program can modify these metabolic markers.

Main Methods:

  • Cross-sectional analysis of 349 children (ages 11-14) measuring VO2max, BMI, skinfolds, and plasma insulin/glucose.
  • LTPA and pubertal status assessed via questionnaires.
  • Intervention group: 8-week aerobic exercise program with follow-up measurements.

Main Results:

  • Insulin levels strongly correlated with BMI, adiposity, pubertal stage, and VO2max, but not LTPA.
  • Fasting glucose correlated with adiposity in males but not females.
  • Children with improved VO2max showed significantly greater insulin reduction compared to those without improvement.

Conclusions:

  • Adiposity is a primary driver of fasting insulin levels in children.
  • Increasing VO2max through exercise effectively reduces elevated insulin levels.
  • LTPA's effect on insulin is indirect, contingent on its ability to improve VO2max.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...